Sell 11/21/2024Upgraded
American Oncology Network, Inc. (AONC) was upgraded to D from D- on 11/21/2024 due to a substantial increase in the efficiency index, total return index and volatility index.

Sell 10/8/2024Upgraded
American Oncology Network, Inc. (AONC) was upgraded to D- from E+ on 10/8/2024 due to an increase in the total return index and volatility index.

Sell 9/20/2024Downgrade
American Oncology Network, Inc. (AONC) was downgraded to E+ from D- on 9/20/2024 due to a decline in the volatility index.

Sell 9/5/2024Upgraded
American Oncology Network, Inc. (AONC) was upgraded to D- from E+ on 9/5/2024 due to an increase in the volatility index and total return index.

Sell 8/19/2024Downgrade
American Oncology Network, Inc. (AONC) was downgraded to E+ from D on 8/19/2024 due to a substantial decline in the efficiency index, total return index and volatility index.

Sell 3/28/2024Upgraded
American Oncology Network, Inc. (AONC) was upgraded to D from E+ on 3/28/2024 due to a substantial increase in the efficiency index, growth index and valuation index.

Sell 12/27/2023Downgrade
American Oncology Network, Inc. (AONC) was downgraded to E+ from D- on 12/27/2023 due to a decline in the total return index, solvency index and volatility index.

Sell 11/16/2023Downgrade
American Oncology Network, Inc. (AONC) was downgraded to D- from D on 11/16/2023 due to a substantial decline in the valuation index, volatility index and efficiency index. Net income declined 220.59% from $1.49M to -$1.79M, and total capital declined 4.95% from $237.41M to $225.66M.

Sell 9/25/2023None
American Oncology Network, Inc. (AONC) was downgraded to D from U on 09/25/2023.